A metabolite of selinexor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

(E)-KPT-330

Item No. 39562

Technical Information
Formal Name
3-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-, 2-(2-pyrazinyl)hydrazide, (2E)-2-propenoic acid
CAS Number
1421923-86-5
Synonyms
  • KTP-330
  • trans Selinexor
Molecular Formula
C17H11F6N7O
Formula Weight
Purity
≥95%
A solid
SMILES
O=C(NNC1=NC=CN=C1)/C=C/N2C=NC(C3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)=N2
InChi Code
InChI=1S/C17H11F6N7O/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)15-26-9-30(29-15)4-1-14(31)28-27-13-8-24-2-3-25-13/h1-9H,(H,25,27)(H,28,31)/b4-1+
InChi Key
DEVSOMFAQLZNKR-DAFODLJHSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    (E)-KPT-330 is a metabolite of the exportin 1 (XPO1/CRM1) inhibitor selinexor.1 It is formed from selinexor by the cytochrome P450 (CYP) isoform CYP3A4.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Mancuso, J. Selinexor (Xpovio), an XPO1 inhibitor and a new class of therapeutics for treating multiple myeloma. Current Drug Synthesis 253-264 (2023).